Literature DB >> 417892

Gentisuric acid: metabolic formation in animals and identification as a metabolite of aspirin in man.

J T Wilson, R L Howell, M W Holladay, G M Brilis, J Chrastil, J T Watson, D F Taber.   

Abstract

Gentisuric acid was synthesized from gentisic acid and glycine ethyl ester. NMR, mass spectrometric and elemental analysis confirmed the product as GU, and physicochemical characteristics were determined. A TLC-densitometric technique was developed to estimate GU and other metabolites of aspirin. Conjugation of gentisic acid with glycine to form GU was catalyzed by a mitochondrial fraction of rat and beef liver. GU was also formed by the rat liver microsomal hydroxylation of salicyluric acid, and phenobarbital pretreatment increased this formation. A random survey showed GU in 76% of SA-positive urines from aspirin-treated patients. Identity of GU in urine from two aspirin-treated patients was confirmed by TLC and mass spectrometric analysis, and hydrolysis of the compound from one patient yielded glycine and gentisic acid. Urine from controls or post-aspirin treatment patients did not show GU by TLC analysis. These results demonstrate for the first time the metabolic formation of GU in animals and its occurrence as a metabolite of aspirin in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417892     DOI: 10.1002/cpt1978236635

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.

Authors:  Mirza Bojić; Carl A Sedgeman; Leslie D Nagy; F Peter Guengerich
Journal:  Eur J Pharm Sci       Date:  2015-03-31       Impact factor: 4.384

2.  Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors:  J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

Review 3.  Aspirin and related derivatives of salicylic acid.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of the salicylates.

Authors:  C J Needs; P M Brooks
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

6.  Disposition of salicylic acid in malnourished Ethiopian children after single oral dose.

Authors:  M Ashton; P Bolme; G Zerihun; K Holmberg; L K Paalzow
Journal:  Clin Pharmacokinet       Date:  1993-12       Impact factor: 6.447

7.  Urinary excretion of aspirin.

Authors:  B Elliot Cham; J H Dykman; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.